In:
Blood, American Society of Hematology, Vol. 131, No. 15 ( 2018-04-12), p. 1743-1754
Abstract:
Circulating levels of murine CCL9 and human homolog CCL15 are increased during cGVHD. Targeting CCL9 in vivo reverses murine cGVHD.
Type of Medium:
Online Resource
ISSN:
0006-4971
,
1528-0020
DOI:
10.1182/blood-2017-08-800623
Language:
English
Publisher:
American Society of Hematology
Publication Date:
2018
detail.hit.zdb_id:
1468538-3
detail.hit.zdb_id:
80069-7